Request for Covid-19 Impact Assessment of this Report

Medical Devices

Global Non-Insulin Therapies for Diabetes Market Data Survey Report 2025

  • HEY2811524
  • 98 Pages
  • November 2018
  • Medical Devices
Download Sample    Get Discount   
 
Summary

The global Non-Insulin Therapies for Diabetes market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including:

Global market size and forecast

Regional market size, production data and export & import

Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)

Major Application

Major Type

Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:

GSK

Eli Lilly

Sumitomo Dainippon Pharma

Intarcia Therapeutics

Servier

Jiangsu Hansoh Pharmaceutical

Jiangsu Hansoh Pharmaceutical

Emisphere

Uni-Bio Science Group

Takeda

3SBio

Merck

Dong-A Pharmaceutical

Luye Pharma Group

Eurofarma

Geropharm

Alkem Labs

SatRx

Pfizer

Jiangsu Hengrui Medicine

Major applications as follows:

Hospital Pharmacy

Retail Pharmacies

Online Pharmacy

Others

Major Type as follows:

Alpha-glucosidase Inhibitors

Amylin Agonists

Biguanides

Dipeptidyl Peptidase-4 (DPP4) Inhibitors

Glinides / Meglitinides

GLP-1 Analogs / GLP-1 Agonists

Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors

Sulfonylureas

Thiazolidinediones

Others

Regional market size, production data and Trade:

Asia-Pacific

North America

Europe

South America

Middle East & Africa

Table of Contents

1 Global Market Overview

1.1 Scope of Statistics

1.1.1 Scope of Products

1.1.2 Scope of Manufacturers

1.1.3 Scope of Application

1.1.5 Scope of Regions/Countries

1.2 Global Market Size

2 Regional Market

2.1 Regional Production

2.2 Regional Demand

2.3 Regional Trade

3 Key Manufacturers

3.1 GSK

3.1.2 Company Information

3.1.2 Product Specifications

3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.2 Eli Lilly

3.2.1 Company Information

3.2.2 Product Specifications

3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.3 Sumitomo Dainippon Pharma

3.3.1 Company Information

3.3.2 Product Specifications

3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.4 Intarcia Therapeutics

3.4.1 Company Information

3.4.2 Product Specifications

3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.5 Servier

3.5.1 Company Information

3.5.2 Product Specifications

3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.6 Jiangsu Hansoh Pharmaceutical

3.6.1 Company Information

3.6.2 Product Specifications

3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.7 Jiangsu Hansoh Pharmaceutical

3.7.1 Company Information

3.7.2 Product Specifications

3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.8 Emisphere

3.8.1 Company Information

3.8.2 Product Specifications

3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.9 Uni-Bio Science Group

3.9.1 Company Information

3.9.2 Product Specifications

3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.10 Takeda

3.10.1 Company Information

3.10.2 Product Specifications

3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.11 3SBio

3.12 Merck

3.13 Dong-A Pharmaceutical

3.14 Luye Pharma Group

3.15 Eurofarma

3.16 Geropharm

3.17 Alkem Labs

3.18 SatRx

3.19 Pfizer

3.20 Jiangsu Hengrui Medicine

4 Major Application

4.1 Hospital Pharmacy

4.1.1 Overview

4.1.2 Hospital Pharmacy Market Size and Forecast

4.2 Retail Pharmacies

4.2.1 Overview

4.2.2 Retail Pharmacies Market Size and Forecast

4.3 Online Pharmacy

4.3.1 Overview

4.3.2 Online Pharmacy Market Size and Forecast

4.4 Others

4.4.1 Overview

4.4.2 Others Market Size and Forecast

5 Market by Type

5.1 Alpha-glucosidase Inhibitors

5.1.1 Overview

5.1.2 Alpha-glucosidase Inhibitors Market Size and Forecast

5.2 Amylin Agonists

5.2.1 Overview

5.2.2 Amylin Agonists Market Size and Forecast

5.3 Biguanides

5.3.1 Overview

5.3.2 Biguanides Market Size and Forecast

5.4 Dipeptidyl Peptidase-4 (DPP4) Inhibitors

5.4.1 Overview

5.4.2 Dipeptidyl Peptidase-4 (DPP4) Inhibitors Market Size and Forecast

5.5 Glinides / Meglitinides

5.5.1 Overview

5.5.2 Glinides / Meglitinides Market Size and Forecast

5.6 Glinides / Meglitinides

5.6.1 Overview

5.6.2 Glinides / Meglitinides Market Size and Forecast

5.7 Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors

5.7.1 Overview

5.7.2 Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors Market Size and Forecast

5.8 Sulfonylureas

5.8.1 Overview

5.8.2 Sulfonylureas Market Size and Forecast

5.9 Thiazolidinediones

5.9.1 Overview

5.9.2 Thiazolidinediones Market Size and Forecast

5.10 Others

5.10.1 Overview

5.10.2 Others Market Size and Forecast

6 Conclusion

Tab Regional Production 2012-2017 (Million USD)

Tab Regional Production 2012-2017 (Volume)

Tab Regional Demand and CAGR 2012-2017 (Million USD)

Tab Regional Demand and CAGR 2012-2017 (Volume)

Tab Regional Demand Forecast and CAGR 2018-2025 (Million USD)

Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)

Tab Sales Revenue, Volume, Price, Cost and Margin of GSK

Tab Sales Revenue, Volume, Price, Cost and Margin of Eli Lilly

Tab Sales Revenue, Volume, Price, Cost and Margin of Sumitomo Dainippon Pharma

Tab Sales Revenue, Volume, Price, Cost and Margin of Intarcia Therapeutics

Tab Sales Revenue, Volume, Price, Cost and Margin of Servier

Tab Sales Revenue, Volume, Price, Cost and Margin of Jiangsu Hansoh Pharmaceutical

Tab Sales Revenue, Volume, Price, Cost and Margin of Jiangsu Hansoh Pharmaceutical

Tab Sales Revenue, Volume, Price, Cost and Margin of Emisphere

Tab Sales Revenue, Volume, Price, Cost and Margin of Uni-Bio Science Group

Tab Sales Revenue, Volume, Price, Cost and Margin of Takeda

Tab Sales Revenue, Volume, Price, Cost and Margin of 3SBio

Tab Sales Revenue, Volume, Price, Cost and Margin of Merck

Tab Sales Revenue, Volume, Price, Cost and Margin of Dong-A Pharmaceutical

Tab Sales Revenue, Volume, Price, Cost and Margin of Luye Pharma Group

Tab Sales Revenue, Volume, Price, Cost and Margin of Eurofarma

Tab Sales Revenue, Volume, Price, Cost and Margin of Geropharm

Tab Sales Revenue, Volume, Price, Cost and Margin of Alkem Labs

Tab Sales Revenue, Volume, Price, Cost and Margin of SatRx

Tab Sales Revenue, Volume, Price, Cost and Margin of Pfizer

Tab Sales Revenue, Volume, Price, Cost and Margin of Jiangsu Hengrui Medicine

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

France Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares

  • Publish Date: April 1, 2019
  • $450
Germany Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
    &nb...

  • Publish Date: April 1, 2019
  • $450
Italy Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
 &nb...

  • Publish Date: April 1, 2019
  • $450